Dupont Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q3 | – | Sell |
-14,399
| Closed | -$910K | – | 625 |
|
|
2014
Q2 | $910K | Buy |
14,399
+4,900
| +52% | +$310K | 0.01% | 513 |
|
|
2014
Q1 | $638K | Sell |
9,499
-4,690
| -33% | -$315K | 0.01% | 568 |
|
|
2013
Q4 | $913K | Sell |
14,189
-1,734
| -11% | -$112K | 0.02% | 511 |
|
|
2013
Q3 | $1.02M | Sell |
15,923
-39,269
| -71% | -$2.51M | 0.02% | 476 |
|
|
2013
Q2 | $1.71M | Buy |
+55,192
| New | +$1.71M | 0.03% | 400 |
|